HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dual transgenic reporter mice as a tool for monitoring expression of glial fibrillary acidic protein.

Abstract
Glial fibrillary acidic protein (GFAP) is the major intermediate filament protein of astrocytes, and its expression changes dramatically during development and following injury. To facilitate study of the regulation of GFAP expression, we have generated dual transgenic mice expressing both firefly luciferase under the control of a 2.2 kb human GFAP promoter and Renilla luciferase under the control of a 0.5 kb human Glyceraldehyde 3 phosphate dehydrogenase (GAPDH) promoter for normalization of the GFAP signal. The GFAP-fLuc was highly expressed in brain compared to other tissues, and was limited to astrocytes, whereas the GAPDH-RLuc was more widely expressed. Normalization of the GFAP signal to the GAPDH signal reduced the inter-individual variability compared to using the GFAP signal alone. The GFAP/GAPDH ratio correctly reflected the up-regulation of GFAP that occurs following retinal degeneration in FVB/N mice because of the rd mutation. Following kainic acid-induced seizures, changes in the GFAP/GAPDH ratio precede those in total GFAP protein. In knock-in mice expressing the R236H Alexander disease mutant, GFAP promoter activity is only transiently elevated and may not entirely account for the accumulation of GFAP protein that takes place.
AuthorsWoosung Cho, Tracy L Hagemann, Delinda A Johnson, Jeffrey A Johnson, Albee Messing
JournalJournal of neurochemistry (J Neurochem) Vol. 110 Issue 1 Pg. 343-51 (Jul 2009) ISSN: 1471-4159 [Electronic] England
PMID19457099 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Biomarkers
  • Glial Fibrillary Acidic Protein
  • Luciferases
  • Luciferases, Renilla
  • Luciferases, Firefly
  • Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)
Topics
  • Alexander Disease (genetics, metabolism)
  • Animals
  • Biomarkers (analysis, metabolism)
  • Brain (metabolism)
  • Drug Evaluation, Preclinical (methods)
  • Epilepsy (genetics, metabolism)
  • Gene Expression Regulation (genetics)
  • Gene Knock-In Techniques
  • Genes, Reporter (genetics)
  • Glial Fibrillary Acidic Protein (genetics, metabolism)
  • Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) (genetics, metabolism)
  • Humans
  • Luciferases (genetics)
  • Luciferases, Firefly (genetics)
  • Luciferases, Renilla (genetics)
  • Mice
  • Mice, Neurologic Mutants
  • Mice, Transgenic
  • Molecular Biology (methods)
  • Promoter Regions, Genetic (genetics)
  • Retinal Degeneration (genetics, metabolism)
  • Transgenes (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: